Acrivon Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Acrivon Therapeutics Inc
CIK #0001781174
EDGAR Form CIK 2011 - 2026
10-K [0001781174]
10-Q [0001781174]
3 [0001781174]
4 [0001781174]
8-K [0001781174]
D [0001781174]
SC 13D [0001781174]
SC 13G [0001781174]
Form 13D/13G Filer Form 13D/13G Subject Filed
Citadel Advisors LLC Acrivon Therapeutics Inc [2025-11-21]
Marshall Wace North America LP Acrivon Therapeutics Inc [2023-02-14]
Chione Ltd Acrivon Therapeutics Inc [2022-11-28]
RA Capital Management LP Acrivon Therapeutics Inc [2022-11-28]
Sands Capital Life Sciences Pulse Fund II LP Acrivon Therapeutics Inc [2022-11-25]
Citadel Advisors LLC Acrivon Therapeutics Inc [2022-11-21]
Perceptive Advisors LLC Acrivon Therapeutics Inc [2022-11-18]
Form 3/4/5 Subject 2011 - 2026
Palani Santhosh
Acrivon Therapeutics Inc
Magovcevic-Liebisch Ivana
DiRocco Derek
BAUM Charles M
Shacham Sharon
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II LP
RA Capital Management LP
Kolchinsky Peter
Tomsicek Michael John
Blume-Jensen Peter
Masson Kristina
Peterson Katharine
Mirza Mansoor Raza
Miller Mary
Levy Adam D
Devroe Eric
Gamelin Erick
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Holm-Jorgensen Rasmus
Cuillerot Jean-Marie
Nikolaou Anastasis
Hadjimichael Andreas
Chione Ltd
Czernik Marcin
Smolokowski Wiaczeslaw
Wellington Biomedical Innovation Master Investors Cayman I
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 31,900 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 417,210 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 185,495 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 186,728 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 94,946 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 132,925 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 129,760 $0.00
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 174,068 $0.00
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-21 Tax withheld 14,265 $1.53 21,825
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-14 Tax withheld 217 $1.63 354
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-14 Tax withheld 723 $1.63 1,178
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-14 Tax withheld 471 $1.63 768
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-14 Tax withheld 116 $1.63 189
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-14 Tax withheld 1,302 $1.63 2,122
Acrivon Therapeutics Inc ACRV
Common Stock
2026-02-14 Tax withheld 579 $1.63 944
Acrivon Therapeutics Inc ACRV
Common Stock
2026-01-17 Tax withheld 659 $1.98 1,305
Acrivon Therapeutics Inc ACRV
Common Stock
2026-01-14 Buy 49,000 $1.68 82,320
Acrivon Therapeutics Inc ACRV
Common Stock
2026-01-14 Buy 8,832 $1.70 15,014
Acrivon Therapeutics Inc ACRV
Common Stock
2026-01-13 Buy 10,000 $1.72 17,200
Acrivon Therapeutics Inc ACRV
Common Stock
2025-11-21 Tax withheld 19,904 $2.30 45,779
showing 20 of 184 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com